Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
David A. Bennett, M.D., Laurel A. Beckett, Ph.D., Anne M. Murray, M.D., M.Sc., Kathleen M. Shannon, M.D., Christopher G. Goetz, M.D., David M. Pilgrim, M.D., and Denis A. Evans, M.D.
Background Older people frequently have signs of parkinsonism,but information about the prevalence of parkinsonism and mortalityamong those with the condition in the community is limited.
Methods A stratified random sample of 467 residents of EastBoston, Massachusetts, 65 years of age or older, were givenstructured neurologic examinations. Using uniform, specifiedcombinations of parkinsonian signs, we estimated the prevalenceof four categories of signs bradykinesia, gait disturbance,rigidity, and tremor and of parkinsonism, defined asthe presence of two or more categories. We did not study Parkinson'sdisease because it could not be distinguished from other conditionsthat can cause parkinsonism. Proportional-hazards models wereused to compare the risk of death among people with and thosewithout parkinsonism.
Results One hundred fifty-nine persons had parkinsonism, 301did not, and 7 could not be classified. The overall prevalenceestimates were 14.9 percent for people 65 to 74 years of age,29.5 percent for those 75 to 84, and 52.4 percent for those85 and older. With a mean follow-up period of 9.2 years, 124persons with parkinsonism (78 percent) and 146 persons withoutit (49 percent) died. Adjusted for age and sex, the overallrisk of death among people with parkinsonism was 2.0 (95 percentconfidence interval, 1.6 to 2.6) times that among people withoutit. Among people with parkinsonism, the presence of gait disturbancewas associated with an increased risk of death.
Conclusions Parkinsonism is very common among people over theage of 65, and its prevalence increases markedly with age. Parkinsonismis associated with a twofold increase in the risk of death,which is strongly related to the presence of a gait disturbance.
Source Information
From the Rush Institute on Aging (D.A.B., L.A.B., A.M.M., D.A.E.) and the Department of Neurological Sciences (D.A.B., K.M.S., C.G.G.), Rush University and RushPresbyterianSt. Luke's Medical Center, Chicago; and the Harvard Community Health Plan, Boston (D.M.P.).
Address reprint requests to Dr. Bennett at the Rush Institute on Aging, 1645 W. Jackson Blvd., Suite 675, Chicago, IL 60612.
Addy, C., Assaid, C., Hreniuk, D., Stroh, M., Xu, Y., Herring, W. J., Ellenbogen, A., Jinnah, H. A., Kirby, L., Leibowitz, M. T., Stewart, R. M., Tarsy, D., Tetrud, J., Stoch, S. A., Gottesdiener, K., Wagner, J.
(2009). Single-Dose Administration of MK-0657, an NR2B-Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease. J Clin Pharmacol
49: 856-864
[Abstract][Full Text]
Buchman, A. S., Boyle, P. A., Wilson, R. S., Fleischman, D. A., Leurgans, S., Bennett, D. A.
(2009). Association Between Late-Life Social Activity and Motor Decline in Older Adults. Arch Intern Med
169: 1139-1146
[Abstract][Full Text]
Driver, J. A., Logroscino, G., Gaziano, J. M., Kurth, T.
(2009). Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology
72: 432-438
[Abstract][Full Text]
Louis, E. D., Brickman, A. M., DeCarli, C., Small, S. A., Marder, K., Schupf, N., Brown, T. R.
(2008). Quantitative Brain Measurements in Community-Dwelling Elderly Persons With Mild Parkinsonian Signs. Arch Neurol
65: 1649-1654
[Abstract][Full Text]
Caslake, R, Moore, J N, Gordon, J C, Harris, C E, Counsell, C
(2008). Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J. Neurol. Neurosurg. Psychiatry
79: 1202-1207
[Abstract][Full Text]
Ishihara, L. S, Cheesbrough, A., Brayne, C., Schrag, A.
(2007). Estimated life expectancy of Parkinson's patients compared with the UK population. J. Neurol. Neurosurg. Psychiatry
78: 1304-1309
[Abstract][Full Text]
Chan, L-L, Rumpel, H, Yap, K, Lee, E, Loo, H-V, Ho, G-L, Fook-Chong, S, Yuen, Y, Tan, E-K
(2007). Case control study of diffusion tensor imaging in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry
78: 1383-1386
[Abstract][Full Text]
Louis, E. D., Schupf, N., Tang, M. X., Marder, K., Luchsinger, J. A.
(2007). Mild Parkinsonian Signs and Plasma Homocysteine Concentration in Community-Dwelling Elderly Individuals. Arch Neurol
64: 1646-1651
[Abstract][Full Text]
Clarke, C E
(2007). Parkinson's disease. BMJ
335: 441-445
[Full Text]
Zubal, I. G., Early, M., Yuan, O., Jennings, D., Marek, K., Seibyl, J. P.
(2007). Optimized, Automated Striatal Uptake Analysis Applied to SPECT Brain Scans of Parkinson's Disease Patients. JNM
48: 857-864
[Abstract][Full Text]
Rozet, I., Muangman, S., Vavilala, M. S., Lee, L. A., Souter, M. J., Domino, K. J., Slimp, J. C., Goodkin, R., Lam, A. M.
(2006). Clinical Experience with Dexmedetomidine for Implantation of Deep Brain Stimulators in Parkinson's Disease. Anesth. Analg.
103: 1224-1228
[Abstract][Full Text]
Shah, R. C., Wilson, R. S., Bienias, J. L., Arvanitakis, Z., Evans, D. A., Bennett, D. A.
(2006). Blood pressure and lower limb function in older persons.. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
61: 839-843
[Abstract][Full Text]
Taylor, K. S M, Counsell, C.
(2006). Is it Parkinson's disease, and if not, what is it?. PN
6: 154-165
[Full Text]
Louis, E. D., Luchsinger, J. A.
(2006). History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals.. Arch Neurol
63: 717-722
[Abstract][Full Text]
Boyle, P. A., Wilson, R. S., Aggarwal, N. T., Arvanitakis, Z., Kelly, J., Bienias, J. L., Bennett, D. A.
(2005). Parkinsonian signs in subjects with mild cognitive impairment. Neurology
65: 1901-1906
[Abstract][Full Text]
Elbaz, A., Ripert, M., Tavernier, B., Fevrier, B., Zureik, M., Gariepy, J., Alperovitch, A., Tzourio, C.
(2005). Common Carotid Artery Intima-Media Thickness, Carotid Plaques, and Walking Speed. Stroke
36: 2198-2202
[Abstract][Full Text]
Burns, J. M., Galvin, J. E., Roe, C. M., Morris, J. C., McKeel, D. W.
(2005). The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology
64: 1397-1403
[Abstract][Full Text]
Louis, E. D., Schupf, N., Manly, J., Marder, K., Tang, M. X., Mayeux, R.
(2005). Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology
64: 1157-1161
[Abstract][Full Text]
Louis, E. D., Tang, M. X., Schupf, N., Mayeux, R.
(2005). Functional Correlates and Prevalence of Mild Parkinsonian Signs in a Community Population of Older People. Arch Neurol
62: 297-302
[Abstract][Full Text]
Arvanitakis, Z., Wilson, R. S., Schneider, J. A., Bienias, J. L., Evans, D. A., Bennett, D. A.
(2004). Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology
63: 996-1001
[Abstract][Full Text]
Murray, A. M., Bennett, D. A., Mendes de Leon, C. F., Beckett, L. A., Evans, D. A.
(2004). A Longitudinal Study of Parkinsonism and Disability in a Community Population of Older People. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
59: M864-M870
[Abstract][Full Text]
Jennings, D. L., Seibyl, J. P., Oakes, D., Eberly, S., Murphy, J., Marek, K.
(2004). (123I) {beta}-CIT and Single-Photon Emission Computed Tomographic Imaging vs Clinical Evaluation in Parkinsonian Syndrome: Unmasking an Early Diagnosis. Arch Neurol
61: 1224-1229
[Abstract][Full Text]
Louis, E. D., Tang, M. X., Mayeux, R.
(2004). Parkinsonian Signs in Older People in a Community-Based Study: Risk of Incident Dementia. Arch Neurol
61: 1273-1276
[Abstract][Full Text]
Herlofson, K., Lie, S. A., Arsland, D., Larsen, J. P.
(2004). Mortality and Parkinson disease: A community based study. Neurology
62: 937-942
[Abstract][Full Text]
Friedman, J. H., Fernandez, H. H., Trieschmann, M. M.
(2004). Parkinsonism in a Nursing Home: Underrecognition. J Geriatr Psychiatry Neurol
17: 39-41
[Abstract]
Knopman, D. S., Boeve, B. F., Petersen, R. C.
(2003). Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia. Mayo Clin Proc.
78: 1290-1308
[Abstract]
Schiess, M.
(2003). Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration: Can an NSAID a Day Keep Parkinson Disease Away?. Arch Neurol
60: 1043-1044
[Full Text]
Louis, E. D., Luchsinger, J. A., Tang, M. X., Mayeux, R.
(2003). Parkinsonian signs in older people: Prevalence and associations with smoking and coffee. Neurology
61: 24-28
[Abstract][Full Text]
Van Den Eeden, S. K., Tanner, C. M., Bernstein, A. L., Fross, R. D., Leimpeter, A., Bloch, D. A., Nelson, L. M.
(2003). Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity. Am J Epidemiol
157: 1015-1022
[Abstract][Full Text]
Wilson, R. S., Schneider, J. A., Bienias, J. L., Evans, D. A., Bennett, D. A.
(2003). Parkinsonianlike Signs and Risk of Incident Alzheimer Disease in Older Persons. Arch Neurol
60: 539-544
[Abstract][Full Text]
Grondin, R., Cass, W. A., Zhang, Z., Stanford, J. A., Gash, D. M., Gerhardt, G. A.
(2003). Glial Cell Line-Derived Neurotrophic Factor Increases Stimulus-Evoked Dopamine Release and Motor Speed in Aged Rhesus Monkeys. J. Neurosci.
23: 1974-1980
[Abstract][Full Text]
Elbaz, A., Bower, J. H., Peterson, B. J., Maraganore, D. M., McDonnell, S. K., Ahlskog, J. E., Schaid, D. J., Rocca, W. A.
(2003). Survival Study of Parkinson Disease in Olmsted County, Minnesota. Arch Neurol
60: 91-96
[Abstract][Full Text]
Levy, G., Tang, M.-X., Louis, E.D., Cote, L.J., Alfaro, B., Mejia, H., Stern, Y., Marder, K.
(2002). The association of incident dementia with mortality in PD. Neurology
59: 1708-1713
[Abstract][Full Text]
Parashos, S. A., Maraganore, D. M., O'Brien, P. C., Rocca, W. A.
(2002). Medical Services Utilization and Prognosis in Parkinson Disease: A Population-Based Study. Mayo Clin Proc.
77: 918-925
[Abstract]
Wilson, R. S., Schneider, J. A., Beckett, L. A., Evans, D. A., Bennett, D. A.
(2002). Progression of gait disorder and rigidity and risk of death in older persons. Neurology
58: 1815-1819
[Abstract][Full Text]
Kis, B., Schrag, A., Ben-Shlomo, Y., Klein, C., Gasperi, A., Spoegler, F., Schoenhuber, R., Pramstaller, P. P.
(2002). Novel three-stage ascertainment method: Prevalence of PD and parkinsonism in South Tyrol, Italy. Neurology
58: 1820-1825
[Abstract][Full Text]
Wood, B H, Bilclough, J A, Bowron, A, Walker, R W
(2002). Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J. Neurol. Neurosurg. Psychiatry
72: 721-725
[Abstract][Full Text]
Miyasaki, J. M., Martin, W., Suchowersky, O., Weiner, W. J., Lang, A. E.
(2002). Practice parameter: Initiation of treatment for Parkinson's disease: An evidence-based review: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology
58: 11-17
[Abstract][Full Text]
Guttman, M., Slaughter, P. M., Theriault, M.-E., DeBoer, D. P., Naylor, C. D.
(2001). Parkinsonism in Ontario: Increased mortality compared with controls in a large cohort study. Neurology
57: 2278-2282
[Abstract][Full Text]
Chen, R. C., Chang, S. F., Su, C. L., H. Chen, T. H., Yen, M. F., Wu, H. M., Chen, Z. Y., Liou, H. H.
(2001). Prevalence, incidence, and mortality of PD: A door-to-door survey in Ilan County, Taiwan. Neurology
57: 1679-1686
[Abstract][Full Text]
Lees, A. J., Katzenschlager, R., Head, J., Ben-Shlomo, Y.
(2001). Ten-year follow-up of three different initial treatments in de-novo PD: A randomized trial. Neurology
57: 1687-1694
[Abstract][Full Text]
Waite, L M, Broe, G A, Grayson, D A, Creasey, H
(2001). Preclinical syndromes predict dementia: the Sydney older persons study. J. Neurol. Neurosurg. Psychiatry
71: 296-302
[Abstract][Full Text]
Engel, L S, Checkoway, H, Keifer, M C, Seixas, N S, Longstreth, W T Jr, Scott, K C, Hudnell, K, Anger, W K, Camicioli, R
(2001). Parkinsonism and occupational exposure to pesticides. Occup. Environ. Med.
58: 582-589
[Abstract][Full Text]
Aarsland, D., Ballard, C., McKeith, I., Perry, R. H., Larsen, J. P.
(2001). Comparison of Extrapyramidal Signs in Dementia With Lewy Bodies and Parkinson's Disease. J. Neuropsychiatry Clin. Neurosi.
13: 374-379
[Abstract][Full Text]
Prusiner, S. B.
(2001). Neurodegenerative Diseases and Prions. NEJM
344: 1516-1526
[Full Text]
Donnan, P.T., Steinke, D.T., Stubbings, C., Davey, P.G., MacDonald, T.M.
(2000). Selegiline and mortality in subjects with Parkinson's disease: A longitudinal community study. Neurology
55: 1785-1789
[Abstract][Full Text]
Zhang, Z., Andersen, A., Smith, C., Grondin, R., Gerhardt, G., Gash, D.
(2000). Motor Slowing and Parkinsonian Signs in Aging Rhesus Monkeys Mirror Human Aging. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
55: 473B-480
[Abstract][Full Text]
Gill, T. M., DiPietro, L., Krumholz, H. M.
(2000). Role of Exercise Stress Testing and Safety Monitoring for Older Persons Starting an Exercise Program. JAMA
284: 342-349
[Abstract][Full Text]
Chan, D. K. Y., Hung, W T, Wong, A, Hu, E, Beran, R G
(2000). Validating a screening questionnaire for parkinsonism in Australia. J. Neurol. Neurosurg. Psychiatry
69: 117-120
[Abstract][Full Text]
Morgante, L., Salemi, G., Meneghini, F., Di Rosa, A. E., Epifanio, A., Grigoletto, F., Ragonese, P., Patti, F., Reggio, A., Di Perri, R., Savettieri, G.
(2000). Parkinson Disease Survival: A Population-Based Study. Arch Neurol
57: 507-512
[Abstract][Full Text]
Wilson, R. S., Bennett, D. A., Gilley, D. W., Beckett, L. A., Schneider, J. A., Evans, D. A.
(2000). Progression of parkinsonian signs in Alzheimer's disease. Neurology
54: 1284-1289
[Abstract][Full Text]
CLARKE, C E
(2000). Mortality from Parkinson's disease. J. Neurol. Neurosurg. Psychiatry
68: 254-255
[Full Text]
Briley, D. P., Haroon, S., Sergent, S. M., Thomas, S.
(2000). Does leukoaraiosis predict morbidity and mortality?. Neurology
54: 90-90
[Abstract][Full Text]
Smith, C. D., Umberger, G. H., Manning, E. L., Slevin, J. T., Wekstein, D. R., Schmitt, F. A., Markesbery, W. R., Zhang, Z., Gerhardt, G. A., Kryscio, R. J., Gash, D. M.
(1999). Critical decline in fine motor hand movements in human aging. Neurology
53: 1458-1458
[Abstract][Full Text]
Bower, J. H., Maraganore, D. M., McDonnell, S. K., Rocca, W. A.
(1999). Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology
52: 1214-1214
[Abstract][Full Text]
Kuopio, A.-M., Marttila, R. J., Helenius, H., Rinne, U. K.
(1999). Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology
52: 302-302
[Abstract][Full Text]
Litvan, I.
(1998). Parkinsonian Features: When Are They Parkinson Disease?. JAMA
280: 1654-1655
[Full Text]
Lang, A. E., Lozano, A. M.
(1998). Parkinson's Disease- First of Two Parts. NEJM
339: 1044-1053
[Full Text]
Thorogood, M., Armstrong, B., Nichols, T., Hollowell, J.
(1998). Mortality in people taking selegiline: observational study. BMJ
317: 252-254
[Abstract][Full Text]
Hebert, M. A., Gerhardt, G. A.
(1997). Behavioral and Neurochemical Effects of Intranigral Administration of Glial Cell Line-Derived Neurotrophic Factor on Aged Fischer 344 Rats. J. Pharmacol. Exp. Ther.
282: 760-768
[Abstract][Full Text]
Louis, E. D., Marder, K., Cote, L., Tang, M., Mayeux, R.
(1997). Mortality From Parkinson Disease. Arch Neurol
54: 260-264
[Abstract]
Weiner, W.J., Singer, C., Shulman, L.M., Bennett, D. A., Goetz, C. G., Evans, D. A.
(1996). Parkinsonism and Parkinson's Disease. NEJM
334: 1611-1612
[Full Text]
Lees, A J, Head, J, Ben-Shlomo, Y
(1996). Authors' reply. BMJ
312: 704b-705
[Full Text]